Relationships of Executive Functions, Severity of Psychiatric Symptoms With Response to Therapy

NCT04603170 | Completed

• 1 other identifier: 13180899
• Study Type: observational
• Target: 164
• Locations: 1 country
• Sites: 1

Brief Summary

This study was conducted to investigate the moderating role of executive functions in the relationship between the severity of psychiatric symptoms and response to therapy. The statistical population of this study was all outpatients with anxiety disorders and depression who referred to psychiatric clinics.

Conditions

Patient Acceptance of Health Care

Outcome Measures

Primary Outcomes (3)

• Outcome questionnaire

  This questionnaire was designed to assess response to treatment. This questionnaire has the dimension of mental distress or signs of distress, interpersonal relationships, and social role. This 45-item questionnaire is answered on a 5-point Likert scale ranging 0 to 4 (not at all to extremely).Scores range from 0 to180. higher scores mean a worse outcome.

  ONE WEEK

• Brief Symptom Inventory

  This inventory measures the symptoms of psycho-somatization, obsessive-compulsive, interpersonal sensitivity, paranoid thoughts, depression, psychosis, general anxiety, hostility and anxiety. It was answered to questions based on the 5-point Likert scale ranging from 0 to 4 (not at all to perfectly). This questionnaire is 53 items. Scores range from 0 to 212.range of score are higher scores mean a worse outcome and mental health problems.

  ONE WEEK

• Behavior Rating Inventory of Executive Function

  This questionnaire is used to measure the executive functions of adults aged 18 to 90 from their daily performance in the natural environment. It has 75 items that measure factors including response inhibition, shifting, emotional control, self-monitoring, initiation, working memory, planning, material organization, and task monitoring. It was answered to questions based on the 3-point Likert scale ranging from 0 to 2 (not at all to extremely). the scores range 0 to 150. High score is indicator of weak executive functions.

  ONE WEEK

Interventions

DRUG OTHER

taking drug medication prescribed by psychiatrists for at least one month

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

The statistical population included all adult outpatients with anxiety and depression disorders who referred to psychiatric offices in Bojnord city Sample was selected among the clients of psychiatric offices who received the diagnosis of anxiety and depression disorders and volunteer to participate in the study were sample (n=164)

You may qualify if:

• receiving a diagnosis of anxiety and depression disorders, age over 18 years, and taking drug medication prescribed by psychiatrists for at least one month.-

You may not qualify if:

• having psychotic disorders, age under 18 years and absence from treatment.

Sponsors & Collaborators

• Malahat Amani: lead

Study Sites (1)

Malahat Amani

Bojnourd, North Khorsan, Iran

Location

MeSH Terms

Conditions

Patient Acceptance of Health Care

Interventions

Pharmaceutical Preparations

Condition Hierarchy (Ancestors)

Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Malahat amani, ph.d

  University of Bojnord

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Malahat Amani

Study Record Dates

• First Submitted: October 20, 2020
• First Posted: October 26, 2020
• Study Start: January 1, 2019
• Primary Completion: February 1, 2019
• Study Completion: March 1, 2019
• Last Updated: October 28, 2020

Record last verified: 2020-10

Data Sharing

• IPD Sharing: Will not share

Locations

IR (1)